| From : | Alisa Tsuladze <atsuladze@moh.gov.ge> |
| To : | Ekaterine Adamia <eadamia@moh.gov.ge> |
| Subject : | patrick's letter |
| Received On : | 06.07.2020 11:25 |
Dear Patrick and team, hope you are doing well!
Following the WHO's July 4th new release, we have few questions;
Firstly, can you please update us on how to proceed with the trial (as we have received all the medications except for the Remedsivir)? Will the Ritonavir/Lopinavir + interferon arm continued?
Can you please send us an updated protocol if such exists?
Secondly, please advise how are we supposed to handle the drugs that are excluded from the trial? (HCQ and Lopinavir/Ritonavir);
Will be looking forward to your response!
პატივისცემით,
ალისა წულაძე
ჯანმრთელობის დაცვის პოლიტიკის სამმართველო
პოლიტიკის დეპარტამენტი
საქართველოს ოკუპირებული ტერიტორიებიდან დევნილთა,
შრომის, ჯანმრთელობისა და სოციალური დაცვის სამინისტრო
+995-32-2-51-00-26 ext 1125
Best regards,
Alisa Tsuladze, MPH
Health Policy Division
Policy Department
Ministry of Internally Displaced persons from
Occupied Territories, Labor, Health and Social Affairs of Georgia